Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex.

Autor: Köser CU; Department of Genetics, University of Cambridge, Cambridge, UK cuk21@cam.ac.uk., Maurer FP; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jazyk: angličtina
Zdroj: The European respiratory journal [Eur Respir J] 2023 May 05; Vol. 61 (5). Date of Electronic Publication: 2023 May 05 (Print Publication: 2023).
DOI: 10.1183/13993003.02397-2022
Abstrakt: Competing Interests: Conflicts of interest: C.U. Köser is a consultant for Becton Dickinson, the Foundation for Innovative New Diagnostics, the TB Alliance, and the WHO Global TB Programme; C.U. Köser's consulting for Becton Dickinson involves a collaboration with Janssen and Thermo Fisher Scientific; C.U. Köser is collaborating with PZA Innovation and is an unpaid advisor to GenoScreen; has worked as a consultant for QuantuMDx, the Stop TB Partnership, and the WHO Regional Office for Europe; has given a paid educational talk for Oxford Immunotec; and has been an unpaid advisor to BioVersys and Cepheid. Hain Lifescience covered C.U. Köser's travel and accommodation to present at a meeting. F.P. Maurer is an employee of Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
Databáze: MEDLINE